U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07382778) titled 'Efficacy and Safety of Livalozet(R) in Hypercholesterolemic Patients With and Without Diabetes' on Jan. 27.
Brief Summary: A Multi-center, Open-label, Observational Study to Compare and Evaluate the Efficacy and Safety of Livalozet(R) according to the Presence or Absence of Diabetes Mellitus in Hypercholesterolemia Patients
Study Start Date: Oct. 19, 2022
Study Type: OBSERVATIONAL
Condition:
Hypercholesterolemia
Recruitment Status: COMPLETED
Sponsor: JW Pharmaceutical
Published by HT Digital Content Services with permission from Health Daily Digest....